Goodwill and Other Intangible Assets

12 Months Ended

Jun. 30, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

The Company’s intangible assets and goodwill consisted of the following:



	As of June 30, 2014
	Gross Carrying Amount		Accumulated Amortization			Net Book Value		Useful Life
Definite-lived intangibles:
Dealer relationships	$	27,392	$	(27,106	)	$	286	8 years
Patent	1,386		(915		)	471		12 years
Trade name	24,567		(12,966		)	11,601		15 years
Total definite-lived intangibles	53,345		(40,987		)	12,358
Goodwill	5,718		—			5,718
Total intangible assets and goodwill	$	59,063	$	(40,987	)	$	18,076



	As of June 30, 2013
	Gross Carrying Amount		Accumulated Amortization			Net Book Value		Useful Life
Definite-lived intangibles:
Dealer relationships	$	27,392	$	(23,683	)	$	3,709	8 years
Patent	1,386		(799		)	587		12 years
Trade name	24,567		(11,328		)	13,239		15 years
Total definite-lived intangibles	53,345		(35,810		)	17,535
Goodwill	5,718		—			5,718
Total intangible assets and goodwill	$	59,063	$	(35,810	)	$	23,253

Amortization expense recognized on all amortizable intangibles was $5,177, $5,178 and $5,178 for the fiscal years ended June 30, 2014, 2013 and 2012, respectively. As of June 30, 2014, the weighted average remaining useful lives for dealer relationships were 0.1 years, the weighted average remaining useful lives for patents were 4.1 years and the weighted average remaining useful lives for trade names were 7.1 years.

Estimated future amortization expenses as of June 30, 2014 are as follows:



Fiscal Year	As of June 30, 2014
2015	$	2,039
2016	1,753
2017	1,753
2018	1,753
2019	1,647
Thereafter	3,413
	$	12,358

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details